SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : analysts and calls -- Morgan Stanley -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (2)10/1/2002 11:23:53 PM
From: Bob L  Read Replies (1) | Respond to of 31
 
Princeton, New Jersey, Oct. 1 (Bloomberg Data) -- Incyte Genomics Inc. (INCY US) was rated new ``underweight/attractive'' in new coverage by analyst David Witzke at Morgan Stanley.



To: tuck who wrote (2)12/6/2002 7:17:10 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 31
 
stockselector.com

Caroline Copithorne
Morgan Stanley

Last Report
Date Company Recommendation 12-Month
Target Current
Price Expected
Gain

11/5/02 InterMune, Inc. (ITMN) Outperform $69 $30.63 125%

11/1/02 Amgen, Inc. (AMGN) Outperform $75 $49.40 52%

11/1/02 GILEAD SCIENCES INC (GILD) Outperform $55 $39.15 40%

10/31/02 NPS Pharmaceuticals, Inc. (NPSP) Neutral $40 $29.67 35%

8/13/02 VIROPHARMA INC (VPHM) Underperform - - -

8/1/02 GENENTECH INC (DNA) Neutral $46 $34.15 35%

7/31/02 Genzyme Corp (GENZ) Neutral $36 $34.43 5%

7/26/02 MedImmune, Inc (MEDI) Outperform - - -

7/25/02 Chiron Corporation (CHIR) Underperform $33 $40.29 -18%

7/3/02 IDEC Pharmaceuticals Corporation (IDPH) Outperform $66 $32.61 102%

6/14/02 Biogen, Inc (BGEN) Underperform $38 $43.33 -12%

4/2/02 Celgene (CELG) Outperform - - -

11/7/01 RIGEL PHARMACEUTICALS INC (RIGL) Outperform - - -

2/23/00 IMMUNE RESPONSE CP (IMNR) Hold - - -

2/15/00 NEUROCRINE BIOSCIENCES INC (NBIX) Strong Buy - - -

2/9/00 Chiron Corporation (CHIR) Hold - - -

1/5/00 VAXGEN INC (VXGN) No Rating - - -

(site pointer from Erik)